NIVOLUMAB

Clinical trials for NIVOLUMAB explained in plain language.

Never miss a new study

Get alerted when new NIVOLUMAB trials appear

Sign up with your email to follow new studies for NIVOLUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New cocktail of drugs tested for Tough-to-Treat colon cancer

Disease control Terminated

This phase 2 trial is testing whether a combination of four drugs—BMS-986340, nivolumab, trifluridine/tipiracil, and bevacizumab—can help control advanced colorectal cancer that has not responded to standard treatments. The study is for people with a specific type called microsat…

Matched conditions: NIVOLUMAB

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jul 17, 2026 00:00 UTC

NIVOLUMAB

Get alerted when new NIVOLUMAB trials appear

New cocktail of drugs tested for Tough-to-Treat colon cancer